TickerFacts.

A business in context

AQST research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-17 · 0001214659-26-010516

  2. 4 · Ownership change

    Report date 2026-08-14 · 0001214659-26-010474

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001398733-26-000042

  4. 8-K · Current report

    Report date 2026-08-11 · 0001398733-26-000041 · Items 2.02,7.01,9.01

  5. 8-K · Current report

    Report date 2026-08-10 · 0001398733-26-000035 · Items 7.01,8.01,9.01

  6. 4 · Ownership change

    Report date 2026-07-15 · 0001214659-26-008663

  7. 4 · Ownership change

    Report date 2026-06-23 · 0001214659-26-007677

  8. 4 · Ownership change

    Report date 2026-06-15 · 0001214659-26-007511

  9. 4 · Ownership change

    Report date 2026-06-10 · 0001214659-26-007399

  10. 4 · Ownership change

    Report date 2026-06-10 · 0001214659-26-007398

  11. 4 · Ownership change

    Report date 2026-06-10 · 0001214659-26-007397

  12. 8-K · Current report

    Report date 2026-06-10 · 0001398733-26-000033 · Items 5.07,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001398733-26-000030

  14. 8-K · Current report

    Report date 2026-05-12 · 0001398733-26-000029 · Items 1.01,1.02,2.02,2.03,3.02,7.01,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001140361-26-016757

  16. 8-K · Current report

    Report date 2026-03-30 · 0001398733-26-000022 · Items 7.01,9.01

  17. 8-K · Current report

    Report date 2026-03-16 · 0001398733-26-000020 · Items 5.02,7.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001398733-26-000018

  19. 8-K · Current report

    Report date 2026-03-03 · 0001398733-26-000016 · Items 1.01,2.02,3.02,7.01,9.01

  20. 8-K · Current report

    Report date 2026-02-26 · 0001398733-26-000007 · Items 7.01,9.01

  21. 8-K · Current report

    Report date 2026-01-30 · 0001398733-26-000005 · Items 7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-09 · 0001398733-26-000003 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-11-06 · 0001398733-25-000030 · Items 7.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001398733-25-000028

  25. 8-K · Current report

    Report date 2025-11-05 · 0001398733-25-000027 · Items 2.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-10-08 · 0001398733-25-000022 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2025-10-01 · 0001398733-25-000020 · Items 7.01,9.01

  28. 8-K · Current report

    Report date 2025-09-08 · 0001398733-25-000018 · Items 7.01,9.01

  29. 8-K · Current report

    Report date 2025-09-04 · 0001398733-25-000016 · Items 7.01,9.01

  30. 8-K · Current report

    Report date 2025-08-14 · 0001140361-25-031374 · Items 1.01,7.01,9.01

  31. 8-K · Current report

    Report date 2025-08-13 · 0001140361-25-031008 · Items 1.01,7.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001398733-25-000013

  33. 8-K · Current report

    Report date 2025-08-11 · 0001398733-25-000012 · Items 2.02,7.01,9.01

  34. 8-K · Current report

    Report date 2025-07-15 · 0001628280-25-034890 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-06-13 · 0001628280-25-031455 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2025-06-11 · 0001628280-25-030804 · Items 5.07

  37. 8-K · Current report

    Report date 2025-06-02 · 0001628280-25-028813 · Items 7.01,9.01

  38. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-024664

  39. 8-K · Current report

    Report date 2025-05-12 · 0001628280-25-024659 · Items 2.02,7.01,9.01

  40. DEF 14A · Proxy statement

    Report date 2025-06-11 · 0001140361-25-015781

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 14 transaction rows14AExercise / conversion: 2 transaction rows2MTax / exercise payment: 8 transaction rows8FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

27 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-23
2026-06-24
Krop Julie
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock25000.00.71
2026-06-23
2026-06-24
Krop Julie
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock25000.05.02
2026-06-23
2026-06-24
Krop Julie
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
25000.00.0
2026-06-15
2026-06-16
Barber Daniel
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock25000.04.16
2026-06-10
2026-06-12
MORRIS TIMOTHY EA · Grant / award
Acquired
Stock Option (right to purchase)
Derivative security
50500.00.0
2026-06-10
2026-06-12
Krop JulieA · Grant / award
Acquired
Stock Option (Right to Purchase)
Derivative security
50500.00.0
2026-06-10
2026-06-12
Jenkins Abigail L.A · Grant / award
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
50500.00.0
2026-06-10
2026-06-12
Cochran JohnA · Grant / award
Acquired
Stock Option (Right to Purchase)
Derivative security
50500.00.0
2026-06-10
2026-06-12
BROWN GREGORY BA · Grant / award
Acquired
Stock Option (Right to Purchase)
Derivative security
50500.00.0
2026-06-10
2026-06-12
Taglietti MarcoA · Grant / award
Acquired
Stock Option (Right to Purchase)
Derivative security
50500.00.0
2026-06-08
2026-06-09
Korczynski SherryF · Tax / exercise payment
Disposed
Common Stock2714.00.0
2026-05-18
2026-05-19
Zalewski Thomas A.A · Grant / award
Acquired
Common Stock100000.00.0
2026-05-18
2026-05-19
Zalewski Thomas A.A · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
75000.00.0
2026-05-15
2026-05-18
Barber Daniel
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8257.04.29
2026-05-15
2026-05-18
Cioffi MelinaF · Tax / exercise payment
Disposed
Common Stock1667.04.17
2026-05-07
2026-05-11
BRAENDER LORI JF · Tax / exercise payment
Disposed
Common Stock135690.04.23
2026-05-05
2026-05-07
Boyd Peter E.F · Tax / exercise payment
Disposed
Common Stock56778.04.18
2026-05-05
2026-05-07
Barber DanielF · Tax / exercise payment
Disposed
Common Stock335922.04.18
2026-05-05
2026-05-07
TOTH A ERNEST JRF · Tax / exercise payment
Disposed
Common Stock92652.04.18
2026-05-05
2026-05-07
Jung CassieF · Tax / exercise payment
Disposed
Common Stock72734.04.18
2026-05-05
2026-05-07
BRAENDER LORI JF · Tax / exercise payment
Disposed
Common Stock76147.04.18
2025-03-07
2026-04-13
Barber DanielA · Grant / award
Acquired
Performance Stock Units
Derivative security
293100.00.0
2025-03-07
2026-04-13
Boyd Peter E.A · Grant / award
Acquired
Performance Stock Units
Derivative security
60000.00.0
2025-03-07
2026-04-13
Jung CassieA · Grant / award
Acquired
Performance Stock Units
Derivative security
60000.00.0
2025-03-07
2026-04-13
TOTH A ERNEST JRA · Grant / award
Acquired
Performance Stock Units
Derivative security
82500.00.0
2025-03-07
2026-04-13
Korczynski SherryA · Grant / award
Acquired
Performance Stock Units
Derivative security
67500.00.0
2025-03-07
2026-04-13
BRAENDER LORI JA · Grant / award
Acquired
Performance Stock Units
Derivative security
82500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001398733Aquestive Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • MonoSol Rx, Inc. · former SEC name · 2007-05-14 to 2008-03-27

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$57.56M$61.27M
2023-12-31$50.58M$55.43M
2022-12-31$47.68M$54.39M
2021-12-31$50.83M$62.63M
2020-12-31$45.85M$59.15M
2019-12-31$52.61M$68.71M
2018-12-31$67.43M$89.66M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗